Delivery Order SPE2DB22D2206-SPE2DB25FFZ38

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,648.62, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a period of performance through May 31, 2024. The contract does not have a set-aside designation, indicating open competition. In addition to this specific delivery order,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,402.41, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of July 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a ceiling value of $4,647.12. The contract has a firm fixed price pricing type and is set to expire on May 31, 2024. AmerisourceBergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has a ceiling value of $6,058.56 and a completion date of December 12, 2023. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,019.13, is for the procurement of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply product. The contract is a firm fixed-price delivery order with a completion date of January 9, 2025. There was no set-aside designation used for this award. AmerisourceBergen...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,695.27 firm fixed-price contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product used in healthcare. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply product, with a ceiling value of $9,697.52 and a period of performance through November 30, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The $8,452.60 firm fixed price contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,229.88, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 10, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has a ceiling value of $40,563.91 and a completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not set-aside. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFZ38
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,229.88, is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract is a firm-fixed price delivery order with a period of performance through March 10, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated as a set-aside contract.

Generated 6/6/25, 9:51 AM